コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 stromal areas within the macular (6 mm) and foveal (1.5 mm) regions, and choroidal vascularity, whic
3 properties of the human visual system (high foveal acuity and low peripheral acuity) and observers'
4 acy of peripheral selection, suggesting that foveal analysis and peripheral selection operated indepe
8 derwent measurements of superficial and deep foveal and parafoveal vessel density (FVD, PFVD) and cho
11 vealed significant thickening of the retinal foveal and the juxtafoveal area, and histological analys
12 diminished foveal contour, persistent fetal foveal architecture, cystoid macular edema (CME), intrar
13 tion of the retinal inner layers in the 1-mm foveal area is associated with VA, and change in DRIL pr
15 aseline was achieved using a coverage-based, foveal area-weighted IRC parameter (R2 = 0.59; P < .001)
20 nts, respectively; the other 22 patients had foveal atrophy, atrophic RPE lesions, and/or irregular y
21 flow loss and quantitatively for measures of foveal avascular area, parafoveal flow, and vascular den
26 was used to provide quantitative data on the foveal avascular zone (FAZ) features and the total vascu
27 el density (VD), fractal dimension (FD), and foveal avascular zone (FAZ) of superficial and deep capi
28 t colocalized to areas of enlargement of the foveal avascular zone and macular capillary nonperfusion
29 ty in the SRL (0.794 [95% CI, 0.707-0.881]), foveal avascular zone area (0.472 [95% CI, 0.356-0.588])
33 al vessel density, total avascular area, and foveal avascular zone as detected with 6 x 6-mm OCT angi
35 ion was detected between vascular density or foveal avascular zone metrics and hemoglobin A1C or dura
36 luate the area of capillary nonperfusion and foveal avascular zone morphology in patients with RVO.
37 ual acuity was independently associated with foveal avascular zone size and central macular thickness
38 P = .001), there was no association between foveal avascular zone size and peripheral ischemia (r =
43 SDOCT that co-localized to areas of enlarged foveal avascular zone, areas of no flow between capillar
44 cluded greatest linear dimension and area of foveal avascular zone, perifoveal capillary dropout grad
50 Three patients presented with pseudocystic foveal cavitation similar in appearance to macular telan
51 magnification, loss of spatial resolution of foveal cells, and topographical disarray in the cellular
52 g possibilities have been suggested: loss of foveal cells, reduced cortical magnification, loss of sp
54 ving all inner retinal layers present at the foveal center (odds ratio, 0.04; P = 0.001) and a lower
55 probability of having the EZ present at the foveal center (odds ratio, 0.07; P = 0.024) compared wit
57 en when the stimulus is already close to the foveal center and precise execution of the movement may
58 nd outer retinal layers were obtained at the foveal center and the nasal and temporal foveal rims.
59 eeks, by a greater than 145 mum reduction in foveal center field thickness and in 6 of 8 eyes by an i
60 mprised best-corrected visual acuity (BCVA), foveal center field thickness assessed by optical cohere
62 a small, focal hyporeflective lesion at the foveal center in both eyes of the subject with RGS9-asso
64 ppreciation that its enlargement through the foveal center leads to significant vision loss through t
65 retina, and more fluid or material under the foveal center of the retina are more likely to develop s
66 l pigment epithelium fluid; thickness at the foveal center of the retina, subretinal fluid, and subre
72 compared to the control group, except at the foveal center where abnormal persistence of 1 or more in
75 the perifoveal macula, initially sparing the foveal center, and over time often expand and coalesce t
76 f the three major carotenoids present at the foveal center, but the mechanism by which it is produced
77 ding the distance of thickest point from the foveal center, choroidal thickness, choroidal volume, ch
78 eater divergence from normal approaching the foveal center, indicating that cone loss predominates ce
79 esent within the central 1 mm(2) but not the foveal center, or present at the foveal center (P = 0.02
80 h more rapid outer retinal thickening at the foveal center, whereas LPC is associated with earlier ex
86 cones, thus allowing accurate assignment of foveal centers and assessment of variability in macular
88 of sub-retinal fluid (SRF) </=200 mum at the foveal centre relative to a T&E protocol that requires c
91 tive to the controls at all measured points (foveal choroidal thickness, P = 0.042; nasal-500 microns
92 bon synapses and active neurotransmission at foveal cone pedicles are possibly present as early as mi
95 vector delivery mode for safely transducing foveal cones in achromatopsia patients and in other huma
101 The included eyes must present an irregular foveal contour and schitic or cavitated lamellar separat
102 tion, vitreo-laser scar adhesion, diminished foveal contour, persistent fetal foveal architecture, cy
103 he following findings: presence of irregular foveal contour, separation of the layers of the neurosen
104 nced processing speed may lead to overcoming foveal crowding and might be the enabling factor for gen
105 absent in the fovea, earlier studies report foveal crowding upon very brief exposures or following s
108 d for LLVA to be more effective at detecting foveal deficits than BCVA in eyes with increasingly poor
114 was to report the spontaneous resolution of foveal detachment in patients with myopic traction macul
115 t cases of high myopia with foveoschisis and foveal detachment in which the subfoveal fluid had spont
118 15-year-old boy with deep optic disc pit and foveal detachment, before and for 10 years after vitrect
120 ucial and unexpected role for ATF6A in human foveal development and cone function and adds to the lis
124 FT), horizontal and vertical extent of DRIL, foveal DRIL (>500 mum DRIL) hyperreflective foci (HRF),
125 ight motion signals across a narrow range of foveal eccentricities rather than uniformly over the who
126 ain the frequency in which there was minimal foveal edema (<15 mum increase), but non-foveal edema wa
127 mal foveal edema (<15 mum increase), but non-foveal edema was considered severe enough to warrant ret
134 that MPOD is lower in glaucomatous eyes with foveal GCC involvement relative to those without foveal
137 duced visual acuity, bull's eye maculopathy, foveal hyperpigmentation, peripapillary atrophy, dyschro
138 on IRR or GDx VCC can occur in patients with foveal hypoplasia and can therefore aid in the diagnosis
141 lving the RNFL and GCL, signs reminiscent of foveal hypoplasia were observed in patients with ONH.
142 orm layer in the central retinal area (i.e., foveal hypoplasia) was found in more than 80% of patient
144 of gaze fixations, during which the current foveal image is analyzed and the next object to inspect
145 f SC organization: an over-representation of foveal information, size-invariant population codes, cas
146 erior ganglion cell complex (GCC) thickness, foveal inner retinal thickness, cup-to-disc area ratio,
147 baseline risk factors included poor VA, RAP, foveal intraretinal fluid, monthly dosing, and treatment
153 ithelium lesion area of 2.6 mm(2), preserved foveal IS/OS in 4.1% of patients, loss of foveal IS/OS i
154 ed foveal IS/OS in 4.1% of patients, loss of foveal IS/OS in 59.2% of patients, and extensive loss of
156 ibe the presence of continuous ectopic inner foveal layers associated with epiretinal membranes (ERMs
158 The presence of continuous ectopic inner foveal layers in ERMs is a newly described OCT finding a
159 association with abnormalities of the inner foveal layers on spectral-domain optical coherence tomog
160 The presence of continuous ectopic inner foveal layers was identified in 63 out of 194 eyes (32.5
163 y, including presence of cataract (P = .05), foveal leakage on fluorescein angiography (P = .04), and
164 played with a green laser developed a yellow foveal lesion and outer retinal streaks in the superior
166 A 14-year-old boy developed bilateral focal foveal lesions and ellipsoid loss on spectral-domain OCT
168 ingly, the occipital pole (OP), representing foveal locations, showed higher activation for tactile t
169 ing radial scans, 71% of eyes demonstrated a foveal lucency at 1 month, whose size correlated with vi
172 orrected visual acuity (BCVA), postoperative foveal lucency horizontal and vertical size, external li
179 precise and reproducible delineation of the foveal nonflow zone and perifoveal intercapillary area.
181 o model target selection in conjunction with foveal object identification: in parallel and independen
185 inally developed in mouse retina, to explore foveal physiology in the macaque, which permits the repe
188 om the fovea, thus forming a bridge over the foveal pit, was observed in 84% of eyes from patients wi
191 .001), whereas the opposite was found in the foveal region (27% +/- 5.2% vs 32% +/- 3.2%; P < .001).
192 otal ganglion cell population outside of the foveal region and their proportion increased with eccent
194 he occipital pole (OP), corresponding to the foveal representation, even though the stimulus was unse
199 ased ellipsoid zone reflectivity in 4 (25%), foveal retinal detachment in 2 (12%), a dome-shaped macu
200 patients revealed either no abnormalities or foveal retinal pigment epithelium (RPE) changes in 10 an
201 o statistical significant difference for the foveal retinal thickness measurements between the two gr
202 On univariate analysis, presentation age, foveal retinoblastoma (at initial examination), use of T
208 m (RPE) tear, (3) subretinal hemorrhage, (4) foveal scar tissue of recent onset, or (5) CNV before th
213 tical meridian and share a representation of foveal space with iso-eccentricity lines extending acros
214 area of geographic atrophy (GA) and residual foveal sparing (FS), and to identify the minimum FS and
218 rnating hyper- and hypoautofluorescence, and foveal sparing of photoreceptors and RPE, as seen on SD-
219 tly to GA lesion enlargement due to possible foveal sparing, alternative assessments are being explor
223 rreader agreement for measurements of GA and foveal-sparing size were 0.995 and 0.946, respectively.
226 ography and fluorescein angiography of inner foveal structural abnormalities associated with vision l
229 om this study suggest that visual acuity and foveal structure in patients with RP are preserved into
230 ng is increased in advanced disease, central foveal structure is maintained until late stages of dise
231 iciency, which partially mimics the all cone foveal structure of human achromatopsia 2 with CNGA3 mut
232 IP can occur with abnormalities of the inner foveal structure seen on spectral-domain optical coheren
235 m) in ranibizumab-treated patients were mild foveal thickening and prominent subfoveal fluid, and tho
237 area, presence of geographic atrophy, total foveal thickness </=325 mum or >/=425 mum, and elevation
238 vs. 50%; P = 0.03), and greater reduction in foveal thickness (-240 mum vs. -161 mum; P < 0.001).
240 ize (3.3 vs 2.4 DA; p <0.001), greater total foveal thickness (522microm vs 452microm; p<0.001), more
242 anges in visual acuity (letters) and central foveal thickness (CFT) and frequency of injections after
244 main endpoint was the change of the central foveal thickness (CFT) obtained by optical coherence tom
246 ROP and graded for presence of CME, central foveal thickness (CFT), inner nuclear layer thickness, a
249 ted changes in levels with changes in excess foveal thickness (EFT) to identify potential PPFs contri
250 -corrected visual acuity (P = .098), central foveal thickness (P = .472), or choroidal thickness at a
253 bizumab-treated patients with </=10% central foveal thickness [CFT] reduction after 3 injections), im
256 ght percentile was associated with increased foveal thickness and ganglion cell damage (RNFL and GCL-
257 ntravitreal treatment led to reduced central foveal thickness and visual improvement in some patients
259 uring the core studies (P = 0.0203), central foveal thickness at baseline (P = 0.0002) and month 36 (
261 on fluorescein angiography and the change in foveal thickness by optical coherence tomography at 6 mo
263 nterior and posterior inflammatory reaction, foveal thickness measured by optical coherence tomograph
264 ected Snellen visual acuity (VA) and central foveal thickness measured on optical coherence tomograph
265 fewer adjunct patients had CMO (42.7%) or a foveal thickness of >300 mum (47.6%) compared with contr
266 or more improvement in DRSS achieved central foveal thickness of 250 mum or less, compared with 65.2%
267 atistically significant reduction in central foveal thickness overall, and subjects with a low CFH ri
268 tly to intravitreal dexamethasone therapy by foveal thickness reduction and visual acuity improvement
270 At 1 month, the mean (SE) change in central foveal thickness was +9.6 (7.2) mum in treated eyes and
275 or better); (2) cystoid macular edema (CMO), foveal thickness, and macular volume; (3) development of
276 fferences include wider fovea, lower central foveal thickness, and thinner inner retina in eyes of bl
277 Regarding the outcome of change in central foveal thickness, improvement was noted in all genotype
279 gnificance of the central macular thickness (foveal thickness-FT) and choroidal thickness (CT) in the
285 th better presenting visual acuities, lesser foveal thicknesses, and no associated PMMs; vision signi
286 gration of the TZs to the foveal center with foveal thinning and structural disorganization heralded
290 ic map, following a consistent path from the foveal to the peripheral representations of space; their
296 ase, which may contribute to preservation of foveal vision in eyes with MAK-related retinal degenerat
298 sitivity declines sharply in peripheral (vs. foveal) vision and is typically worse in the upper (vs.
300 laucomatous eyes with GCC loss involving the foveal zone on FD-OCT imaging (n = 52) had lower MPOD at
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。